http://www.mail.com/people/892848-kenneth-frazier.html Mail.com - the best personalized free web-based Email en en http://sec-s.uicdn.com/mail.com/2.29/img/mailcom_logo_rss.png http://www.mail.com/people/892848-kenneth-frazier.html http://www.mail.com/business/economy/2055676-generic-competition-cuts-mercks-q1-sales-profit.html Merck & Co. on Wednesday posted disappointing first-quarter results and cut its earnings forecast for the year. But the world's third-largest drugmaker predicted that things would soon improve. Merck was slammed by two factors plaguing most of its rivals: growing competition from generic drugs and unfavorable exchange rates. Major drugmakers in recent yea... Wed, 01 May 2013 20:56:47 GMT http://www.mail.com/business/economy/2055676-generic-competition-cuts-mercks-q1-sales-profit.html 2013-05-01T20:56:47Z http://www.mail.com/sports/other/1947990-scandal-costs-penn-top-41.html STATE COLLEGE, Pa. (AP) — Penn State has released a document sought by some of its critics detailing the agreement with former FBI director Louis Freeh to investigate the Jerry Sandusky child sex abuse scandal, a review that cost the school about $8.1 million. Including the bill to pay Freeh, Penn State's total costs associated with the scandal topped $41... Tue, 12 Mar 2013 12:43:48 GMT http://www.mail.com/sports/other/1947990-scandal-costs-penn-top-41.html 2013-03-12T12:43:48Z http://www.mail.com/business/economy/1924938-bio-box-kenneth-frazier-ceo-drugmaker-merck.html Merck & Co. CEO, Chairman and President Kenneth C. Frazier AGE: 54. HOMETOWN: Philadelphia FAMILY: Married with a teenage son and adult daughter who's an engineer EDUCATION: Bachelor's degree from Pennsylvania State University; law degree from Harvard Law School CAREER: Served in... Fri, 01 Mar 2013 16:34:11 GMT http://www.mail.com/business/economy/1924938-bio-box-kenneth-frazier-ceo-drugmaker-merck.html 2013-03-01T16:34:11Z http://www.mail.com/business/economy/1861592-generic-competition-charges-cut-merck-q4-profit.html Merck & Co.'s fourth-quarter profit fell 7 percent because of hits from generic competition and one-time charges, and the company pushed back plans for seeking approval of a key experimental osteoporosis drug. The quarterly results beat Wall Street expectations, but Merck shares fell Friday as investors learned the company is reviewing safety and efficacy... Fri, 01 Feb 2013 20:09:00 GMT http://www.mail.com/business/economy/1861592-generic-competition-charges-cut-merck-q4-profit.html 2013-02-01T20:09:00Z